Characterizing public participation in Prescription Drug User Fee Act reauthorization, 2010–2021

Therese J Ziaks, Asuka Koda, Reshma Ramachandran, Joseph S Ross, Jason L Schwartz

Open source

DOI
10.1093/haschl/qxag169
Published
2026-07
Container
Health Affairs Scholar
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/haschl/qxag169,
  title = {Characterizing public participation in Prescription Drug User Fee Act reauthorization, 2010–2021},
  author = {Therese J Ziaks and Asuka Koda and Reshma Ramachandran and Joseph S Ross and Jason L Schwartz},
  year = {2026},
  journal = {Health Affairs Scholar},
  doi = {10.1093/haschl/qxag169},
  url = {https://doi.org/10.1093/haschl/qxag169}
}

RIS

TY  - JOUR
TI  - Characterizing public participation in Prescription Drug User Fee Act reauthorization, 2010–2021
AU  - Therese J Ziaks
AU  - Asuka Koda
AU  - Reshma Ramachandran
AU  - Joseph S Ross
AU  - Jason L Schwartz
PY  - 2026
JO  - Health Affairs Scholar
DO  - 10.1093/haschl/qxag169
UR  - https://doi.org/10.1093/haschl/qxag169
ER  - 

APA

Ziaks, T. J., Koda, A., Ramachandran, R., Ross, J. S., & Schwartz, J. L. (2026). Characterizing public participation in Prescription Drug User Fee Act reauthorization, 2010–2021. Health Affairs Scholar. https://doi.org/10.1093/haschl/qxag169

Source records